Publicacións (51) Publicacións nas que participase algún/ha investigador/a

2018

  1. 2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors

    Scientific Reports, Vol. 8, Núm. 1

  2. A complexity scale for clinical trials from the perspective of a pharmacy service

    European Journal of Hospital Pharmacy , Vol. 25, Núm. 5, pp. 251-256

  3. Adult Sox2+ stem cell exhaustion in mice results in cellular senescence and premature aging

    Aging Cell, Vol. 17, Núm. 5

  4. Anakinra for the treatment of undifferentiated systemic auto-inflammatory disease

    European Journal of Clinical Pharmacy, Vol. 20, Núm. 6, pp. 337-339

  5. Auditing and improving surgical antibiotic prophylaxis

    Surgical Infections, Vol. 19, Núm. 7, pp. 679-683

  6. Bilayer polymeric nanocapsules: A formulation approach for a thermostable and adjuvanted E. coli antigen vaccine

    Journal of Controlled Release, Vol. 286, pp. 20-32

  7. Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke

    Annals of Neurology, Vol. 84, Núm. 2, pp. 260-273

  8. Conciliación de medicación al alta hospitalaria: colaboración entre farmacéuticos de atención primaria y atención especializada

    Pharmaceutical care España, Vol. 20, Núm. 5, pp. 352-370

  9. Coronary vascular disease event risk and metabolic syndrome prevalence in patients enrolled in an assertive treatment community program

    Comprehensive Psychiatry, Vol. 81, pp. 28-32

  10. Cure of chronic hepatitis C virus infection in an HIV-coinfected patient with multiple comorbidities and drug interaction challenges

    International Journal of STD and AIDS, Vol. 29, Núm. 9, pp. 933-936

  11. Determination of hemodynamic risk for vascular disease in planar artery bifurcations

    Scientific Reports, Vol. 8, Núm. 1

  12. Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis

    BioDrugs, Vol. 32, Núm. 3, pp. 281-291

  13. Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 61, Núm. 12, pp. 5269-5278

  14. Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury

    American Journal of Nephrology, Vol. 48, Núm. 3, pp. 225-233

  15. Effect of a Structured Pharmaceutical Care Intervention Versus Usual Care on Cardiovascular Risk in HIV Patients on Antiretroviral Therapy: INFAMERICA Study

    Annals of Pharmacotherapy, Vol. 52, Núm. 11, pp. 1098-1108

  16. Epidemiology of home enteral nutrition: An approximation to reality

    Nutricion Hospitalaria, Vol. 35, Núm. 3, pp. 511-518

  17. Evaluation of the use of nab-paclitaxel and gemcitabine in clinical practice

    Journal of Cancer Research and Therapeutics, Vol. 14, Núm. 10, pp. S730-S735

  18. Evidencia de los beneficios de Nexobrid® en quemaduras profundas

    Proyecto Lumbre: Revista Multidisciplinar de Insuficiencia Cutánea Aguda, Mes 16, pp. 76-80

  19. Factors associated with patient satisfaction in an outpatient hospital pharmacy

    European Journal of Hospital Pharmacy , Vol. 25, Núm. 4, pp. 183-188

  20. Fingerprint-based machine learning approach to identify potent and selective 5-HT2BR ligands

    Molecules, Vol. 23, Núm. 5